Home > Where to buy Neurometrix stock after it skyrockets 930%

Where to buy Neurometrix stock after it skyrockets 930%

In the last few days, Neurometrix (NASDAQ: NURO) has been one of the best performing stocks in the world.

This article covers all of the key things you need to know before you invest in Neurometrix. Read on to discover what the company is, why it is rising in value, what our NURO price forecast is and whether or not you should buy Neurometrix shares right now.

If you want to go right ahead and invest immediately, check out the section directly below. Here, you can find our list of the two best places to buy, sell and trade Neurometrix stock in the UK and around the world.

How & where to buy Neurometrix shares online today

To buy NURO stock quickly and easily, click on one of the links below, fill out some basic personal information and fund your account. Then, you can buy the number of NURO shares you want instantly.

We feel these are the two best platforms to buy NURO stock because of their low fees and high-quality user interfaces. Check them out:

eToro

eToro is one of the world's leading multi-asset trading platforms offering some of the lowest commission and fee rates in the industry. It's social copy trading features make it a great choice for those getting started.

Register with eToro instantly

Webull

Financial company driven by technology and offering all-in-one self-directed investment platform that provides excellent user experience.

Register with Webull instantly

What is Neurometrix and why is its share price rising?

Founded in 1996 and based in Woburn, Massachusetts, it is a healthcare company that develops and markets products for the detection, diagnosis, and monitoring of peripheral nerve and spinal cord disorders. It is listed on the Nasdaq stock exchange under the ticker, NURO.

The price of NURO shares have surged following record trading volume after the company’s Quell transcutaneous electric nerve stimulator received “Breakthrough Designation” from the Food and Drug Administration (FDA) to treat fibromyalgia symptoms in adults.

Should I buy Neurometrix shares right now?

If you believe in the company directors, and if you think NURO’s fibromyalgia treatment can achieve commercialisation, the company could be set to generate huge profits, potentially driving its share price up. If this is how you feel after conducting extensive due diligence, buying shares now might be a good idea.

NURO price target 2021

Our Neurometrix price target for 2021 and beyond is as follows: an average 12-month price of $50, which is a huge upgrade on its current market value.

Trade/invest in stocks with just $50
Invest for dividends and get payout on stocks on Ex-Dividend day
Over 11 payment methods, including PayPal
Open my Account

We use cookies to personalise content & ads, provide social media features and offer you a better experience. By continuing to browse the site or clicking "OK, Thanks" you are consenting to the use of cookies on this website.